Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Ciscom Corp. Strengthens Its Board of Directors with Addition of Two Experienced Industry Leaders (click to learn more) Silver North Options GDR Silver Project, Silvertip-Midway District, Yukon (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  V.KHRN.W.H | KHRNF | KHRWF

Healthcare Cannabis
Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line... see more

TSXV:KHRN.H - Post Discussion

Khiron Life Sciences Corp > Q1 May 28th + New PR Agreement
View:
Post by CGCFAN on May 19, 2021 5:35pm

Q1 May 28th + New PR Agreement

<a href="https://investors.khiron.ca/investor-information/news-events/press-releases/detail/213/khiron-to-host-first-quarter-2021-conference-call-on-may">https://investors.khiron.ca/investor-information/news-events/press-releases/detail/213/khiron-to-host-first-quarter-2021-conference-call-on-may</a>
Comment by CGCFAN on May 19, 2021 5:38pm
https://investors.khiron.ca/investor-information/news-events/press-releases/detail/213/khiron-to-host-first-quarter-2021-conference-call-on-may
Comment by TomConstantine on May 20, 2021 10:44pm
Credible sources saying $3 in the next couple of months
Comment by Benedictus on May 21, 2021 1:10am
I'm not discounting the long term potential of Khiron as they continue their clinic buildout, script issuance growth and expand strong Latam brand recognition. But to suggest any credible analyst would suggest this company is worth $3 a share or a 600M fully diluted market cap in a few months is frankly ludicrous. For reference, a 600M market cap would be even higher than the pre private ...more  
Khiron Life Sciences Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

Dealroom for high-potential pre-IPO opportunities